OVERVIEW
DOCUMENTS/REFERENCES
Biological Information
Background Information:
Cytochrome P450 (CYP) inhibition is one of the most common types of drug-drug interactions (DDI) and can be exhibited in either a reversible or time-dependent manner. This assay is designed to determine if a test compound is an irreversible, time-dependent inhibitor of CYP2C8 in human liver microsomes
No. of Assays on Panel:
2
Assays on Panel:
Family
CYP450
Name
Time-dependent CYP2C8 Inhibition (HLM, amodiaquine substrate + NADPH) - US
Item
5215
Protein
Organism
Human
Assay Sub Type
Enzymatic
Family
CYP450
Name
Time-dependent CYP2C8 Inhibition (HLM, amodiaquine substrate - NADPH) - US
Item
5216
Protein
Organism
Human
Assay Sub Type
Enzymatic
Family:
CYP450
Sub Family:
CYP2
Organism:
Human
Construct Details:
Microsomes
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Testing Information
Test Sample Requirements:
Minimum for 1) Screen: 100 µl of 10 mM stock -OR- 1 to 2 mg (pre-weighed). 2) Dose Response: 250 µl of 10 mM stock -OR- 1.5 to 2 mg (pre-weighed).
Turnaround Time
Standard:
10 Business Days
Additional Information
Brand:
Cerep
Testing Location:
USA - St Charles, MO
Questions? Contact Us
You can easily get in touch with a Eurofins Discovery Expert or get help from our Customer Service team. Reach out with questions, or to discuss your specific discovery challenges.
